Wagg, Adrian, et al. “Persistence and Adherence With the New Beta-3 Receptor Agonist, Mirabegron, Versus Antimuscarinics in Overactive Bladder: Early Experience in Canada”. Canadian Urological Association Journal, vol. 9, no. 9-10, Oct. 2015, pp. 343-50, doi:10.5489/cuaj.3098.